Foundry Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $16M | Buy |
36,778
+8,458
| +30% | +$3.4M | 0.85% | 38 |
|
|
2024
Q4 | $10.4M | Sell |
28,320
-17,945
| -39% | -$7.51M | 0.53% | 56 |
|
|
2024
Q3 | $24.1M | Sell |
46,265
-230
| -0.5% | -$123K | 1.19% | 19 |
|
|
2024
Q2 | $25.2M | Buy |
46,495
+5,059
| +12% | +$2.67M | 1.35% | 14 |
|
|
2024
Q1 | $21.5M | Buy |
41,436
+1,265
| +3% | +$629K | 1.15% | 18 |
|
|
2023
Q4 | $18.9M | Sell |
40,171
-4,985
| -11% | -$2.31M | 1.14% | 17 |
|
|
2023
Q3 | $19.7M | Sell |
45,156
-290
| -0.6% | -$132K | 1.22% | 15 |
|
|
2023
Q2 | $20.2M | Sell |
45,446
-355
| -0.8% | -$164K | 1.24% | 17 |
|
|
2023
Q1 | $21.1M | Sell |
45,801
-9,601
| -17% | -$4.57M | 1.33% | 13 |
|
|
2022
Q4 | $28.4M | Sell |
55,402
-775
| -1% | -$394K | 1.57% | 12 |
|
|
2022
Q3 | $25.5M | Buy |
56,177
+425
| +0.8% | +$203K | 1.61% | 8 |
|
|
2022
Q2 | $26.9M | Sell |
55,752
-1,250
| -2% | -$618K | 1.62% | 8 |
|
|
2022
Q1 | $28M | Sell |
57,002
-9,448
| -14% | -$4.32M | 1.43% | 13 |
|
|
2021
Q4 | $30.8M | Sell |
66,450
-875
| -1% | -$368K | 1.09% | 11 |
|
|
2021
Q3 | $25.1M | Buy |
67,325
+8,585
| +15% | +$3.26M | 0.9% | 19 |
|
|
2021
Q2 | $22.4M | Sell |
58,740
-7,460
| -11% | -$2.85M | 0.77% | 23 |
|
|
2021
Q1 | $23.8M | Buy |
66,200
+5,400
| +9% | +$1.74M | 0.78% | 23 |
|
|
2020
Q4 | $19.5M | Sell |
60,800
-7,391
| -11% | -$2.27M | 0.77% | 26 |
|
|
2020
Q3 | $18.3M | Buy |
68,191
+28,766
| +73% | +$7.74M | 0.89% | 15 |
|
|
2020
Q2 | $10.4M | Buy |
+39,425
| New | +$10.5M | 0.51% | 65 |
|
|
2017
Q4 | – | Sell |
-77,510
| Closed | -$14.7M | – | 388 |
|
|
2017
Q3 | $14.7M | Sell |
77,510
-7,575
| -9% | -$1.44M | 0.59% | 40 |
|
|
2017
Q2 | $16M | Buy |
85,085
+13,600
| +19% | +$2.44M | 0.66% | 25 |
|
|
2017
Q1 | $11.8M | Sell |
71,485
-2,175
| -3% | -$346K | 0.49% | 54 |
|
|
2016
Q4 | $10.6M | Buy |
73,660
+10,885
| +17% | +$1.46M | 0.46% | 61 |
|
|
2016
Q3 | $7.87M | Sell |
62,775
-20,471
| -25% | -$2.64M | 0.41% | 88 |
|
|
2016
Q2 | $10.9M | Buy |
83,246
+14,595
| +21% | +$2M | 0.62% | 34 |
|
|
2016
Q1 | $9.54M | Buy |
68,651
+4,021
| +6% | +$537K | 0.94% | 30 |
|
|
2015
Q4 | $9.01M | Sell |
64,630
-1,625
| -2% | -$224K | 0.75% | 38 |
|
|
2015
Q3 | $9.28M | Buy |
+66,255
| New | +$9.96M | 0.81% | 34 |
|
|
2014
Q4 | – | Sell |
-73,094
| Closed | -$8.74M | – | 253 |
|
|
2014
Q3 | $8.74M | Buy |
73,094
+26,781
| +58% | +$3.07M | 0.81% | 44 |
|
|
2014
Q2 | $4.98M | Buy |
46,313
+10,297
| +29% | +$1.06M | 0.46% | 91 |
|
|
2014
Q1 | $3.58M | Sell |
36,016
-1,605
| -4% | -$145K | 0.34% | 103 |
|
|
2013
Q4 | $3.48M | Buy |
+37,621
| New | +$3.34M | 0.31% | 106 |
|
Other funds holding ELV
Foundry Partners's ELV Position: Q1 2025 in Review
Foundry Partners increased its Elevance Health (ELV) stake by 30% in Q1 2025, buying an estimated $3.4M and bringing the position to 36,778 shares worth $16M. The position accounts for 0.85% of the portfolio, ranked #38.
Foundry Partners first reported a position in ELV in Q4 2013 and has held it in 33 quarters since. The position peaked at $30.8M in Q4 2021. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.
- Foundry Partners held 36,778 shares of Elevance Health worth $16M as of Q1 2025.
- Foundry Partners bought 8,458 Elevance Health shares in Q1 2025, an estimated $3.4M.
- Elevance Health made up 0.85% of Foundry Partners's portfolio in Q1 2025, its #38 holding.
- Foundry Partners first reported a position in Elevance Health in Q4 2013 and has held it in 33 quarters since.
- Foundry Partners's Elevance Health position peaked at $30.8M in Q4 2021.
- 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.
Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.